These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30704653)

  • 1. Prescription of Aspirin and Statins in Primary Prevention.
    Hennekens CH; Schuttenberg N; Pfeffer MA
    Prim Care; 2019 Mar; 46(1):13-25. PubMed ID: 30704653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and aspirin: do they really work in women?
    Desai H; Hollingsworth PW; Chugh AR
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):151-62. PubMed ID: 25812803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.
    Lonn E; Grewal J
    Curr Vasc Pharmacol; 2006 Jul; 4(3):253-68. PubMed ID: 16842143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins in the management of dyslipidemias].
    Scheen AJ
    Rev Prat; 2011 Oct; 61(8):1120-6. PubMed ID: 22135981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011-2018.
    Rhee TG; Kumar M; Ross JS; Coll PP
    J Am Geriatr Soc; 2021 May; 69(5):1272-1282. PubMed ID: 33598936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
    Moyad MA; Merrick GS
    Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
    Stirban AO; Tschoepe D
    Diabetes Care; 2008 Feb; 31 Suppl 2():S226-8. PubMed ID: 18227490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.
    Neyt M; De Laet C; Van Brabandt H; Franco O; Ramaekers D
    Acta Cardiol; 2009 Feb; 64(1):1-10. PubMed ID: 19317290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
    De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P
    Infection; 2016 Oct; 44(5):589-97. PubMed ID: 27048184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin in Older Adults: Need for Wider Utilization in Secondary Prevention and Individual Clinical Judgments in Primary Prevention.
    Sehgal M; Wood SK; Ouslander JG; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):511-513. PubMed ID: 28279072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review.
    Arboleda V; Hackworth A; Bonnice S; Gonzalez V; Cabrera D; Colletti C; Baxter C; Aleman Oliva C; Kabir S; Huang J; Khan A; Filoramo S; Ecoff S; Demory Beckler M; Kesselman MM
    J Osteopath Med; 2024 Mar; 124(3):97-106. PubMed ID: 37877246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome.
    Wei L; Fahey T; MacDonald TM
    Br J Clin Pharmacol; 2008 Jul; 66(1):110-6. PubMed ID: 18492127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of statins and aspirin to reduce risks of cardiovascular disease.
    Hebert PR; Pfeffer MA; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):77-80. PubMed ID: 12075395
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin for the primary prevention of cardiovascular disease: latest evidence.
    Capodanno D; Ingala S; Calderone D; Angiolillo DJ
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):633-643. PubMed ID: 31382819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypill: Progress and Challenges to Global Use--Update on the Trials and Policy Implementation.
    Webster R; Rodgers A
    Curr Cardiol Rep; 2015 Dec; 17(12):121. PubMed ID: 26497041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.